BUYO Among Its Peers
End-of-day Nov 10, 2026 · 1 ETFs by YTD
Loading…
Getting the latest data.
KraneShares[…]
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.4% | +0.2% | +2.6% | −2.1% | +20.2% | +24.3% | — | — | +33.5% |
| S&P 500 · VOO | −0.3% | −0.6% | −3.6% | −2.7% | +10.9% | +13.1% | +79.3% | +74.2% | — |
$15 of every $1,000 in BUYO is News
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | NWSANews | Communication Services | 1.54% | $153.88 | 9,483 | $250K |
| 2 | EHCEncompass Health | Healthcare | 1.39% | $138.89 | 1,642 | $226K |
| 3 | ASANAsana | Technology | 1.14% | $114.01 | 17K | $185K |
| 4 | FTDRFrontdoor | Consumer Cyclical | 1.12% | $112.43 | 1,883 | $183K |
| 5 | AMGAffiliated Managers Group | Financial Services | 1.12% | $112.28 | 503 | $183K |
| 6 | MORNMorningstar | Financial Services | 1.12% | $112.16 | 747 | $182K |
| 7 | TDOCTeladoc Health | Healthcare | 1.06% | $106.03 | 20K | $172K |
| 8 | LFSTLifestance Health Group | Healthcare | 1.06% | $105.68 | 12K | $172K |
| 9 | XERSXeris Biopharma | Healthcare | 0.96% | $95.51 | 10K | $155K |
| 10 | NIQNIQ Global Intelligence | Technology | 0.95% | $94.96 | 7,562 | $154K |
| 11 | AMRXAmneal Pharmaceuticals | Healthcare | 0.93% | $93.46 | 7,546 | $152K |
| 12 | MTRNMaterion | Basic Materials | 0.93% | $92.82 | 811 | $151K |
| 13 | AXSAxis Capital | Financial Services | 0.92% | $91.76 | 1,408 | $149K |
| 14 | MTCHMatch Group | Communication Services | 0.89% | $89.44 | 3,726 | $145K |
| 15 | ATIATI | Industrials | 0.86% | $86.49 | 800 | $141K |
BUYO has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | NWSA | News - | 1.54% |
| 2 | EHC | Encompass Health | 1.39% |
| 3 | ASAN | Asana - | 1.14% |
| 4 | FTDR | Frontdoor | 1.12% |
| 5 | AMG | Affiliated Managers Group | 1.12% |
| 6 | MORN | Morningstar | 1.12% |
| 7 | TDOC | Teladoc Health | 1.06% |
| 8 | LFST | Lifestance Health Group | 1.06% |
| 9 | XERS | Xeris Biopharma | 0.96% |
| 10 | NIQ | NIQ Global Intelligence | 0.95% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| BUYO | 1.16 | 1.76 | 18.0% | −10.1% | 1.10 | $89 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | $0.0034 |
| Dec 17, 2024 | Dec 18, 2024 | $0.0107 |